treating relapsed/refractory multiple myeloma with car t-cell therapy
Published 4 years ago • 109 plays • Length 7:13Download video MP4
Download video MP3
Similar videos
-
6:58
investigational car t-cell therapy in relapsed/refractory multiple myeloma
-
34:45
relapsed/refractory multiple myeloma and car t-cell therapy: navigating the patient journey
-
1:17
dr. hari on car t-cell therapy in relapsed/refractory multiple myeloma
-
3:35
bcma-directed car t-cell therapy: outlook
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
1:12
evaluating the role of car t-cell therapy in relapsed/refractory dlbcl
-
4:17
car-t cell therapy cilta-cel for relapsed/refractory myeloma | doris hansen, md | asco 2023
-
4:17
clinical outcomes of relapsed/refractory multiple myeloma patients after bcma-targeted car t the...
-
1:12
causes for relapse in multiple myeloma with car t cells
-
1:39
dr. galal on car t-cell therapy in relapsed/refractory lymphomas
-
3:47
what is car t-cell therapy?
-
1:59
efficacy and safety of cd19-targeted car t-cells for relapsed/refractory all
-
5:27
car t-cell therapy: relapsed/refractory all
-
10:18
ide-cel; bb2121, a bcma-targeted car t-cell therapy, in patients with rrmm: initial karmma results
-
2:44
novel bcma-targeting therapies to treat tce relapsed/refractory multiple myeloma
-
1:16
potential benefits of p-bcma-101 car-t for relapsed/refractory multiple myeloma
-
9:05
targeted treatment options in multiple myeloma
-
2:32
using mrd status to guide treatment for relapsed/refractory multiple myeloma
-
1:56
bb2121 anti-bcma car t-cell therapy in relapsed/refractory mm